These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 30448456)

  • 21. Characteristics comparisons of bacteremia in allogeneic and autologous hematopoietic stem cell-transplant recipients with levofloxacin prophylaxis and influence on resistant bacteria emergence.
    Wang CH; Chang FY; Chao TY; Kao WY; Ho CL; Chen YC; Dai MS; Chang PY; Wu YY; Lin JC
    J Microbiol Immunol Infect; 2018 Feb; 51(1):123-131. PubMed ID: 27103500
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characteristics of gram-negative bacteremia during febrile neutropenia among allogeneic hematopoietic stem cell transplant recipients on levofloxacin prophylaxis.
    Ogura S; Kimura M; Takagi S; Mitsuki T; Yuasa M; Kageyama K; Kaji D; Nishida A; Taya Y; Ishiwata K; Yamamoto H; Asano-Mori Y; Yamamoto G; Uchida N; Wake A; Taniguchi S; Araoka H
    Eur J Clin Microbiol Infect Dis; 2021 May; 40(5):941-948. PubMed ID: 33185742
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enterococcal bacteremia in febrile neutropenic children and adolescents with underlying malignancies, and clinical impact of vancomycin resistance.
    Bae KS; Shin JA; Kim SK; Han SB; Lee JW; Lee DG; Chung NG; Cho B; Jeong DC; Kang JH
    Infection; 2019 Jun; 47(3):417-424. PubMed ID: 30565009
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bloodstream Infection Due to Vancomycin-resistant Enterococcus Is Associated With Increased Mortality After Hematopoietic Cell Transplantation for Acute Leukemia and Myelodysplastic Syndrome: A Multicenter, Retrospective Cohort Study.
    Papanicolaou GA; Ustun C; Young JH; Chen M; Kim S; Woo Ahn K; Komanduri K; Lindemans C; Auletta JJ; Riches ML;
    Clin Infect Dis; 2019 Oct; 69(10):1771-1779. PubMed ID: 30649224
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Enterococcal Bacteremia in Children With Malignancies and Following Hematopoietic Stem Cell Transplantation: A 15-Year Single-Center Experience.
    Friedman G; Stepensky P; Abu Ahmad W; Masarwa R; Temper V; Oster Y; Amit S; Averbuch D
    Pediatr Infect Dis J; 2020 Apr; 39(4):318-324. PubMed ID: 31990889
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical outcomes of intestinal transplant recipients colonized with multidrug-resistant organisms: a retrospective study.
    Simkins J; Morris MI; Camargo JF; Vianna R; Beduschi T; Abbo LM
    Transpl Int; 2017 Sep; 30(9):924-931. PubMed ID: 28544183
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Colonization and infection with vancomycin-resistant Enterococcus among patients with cancer.
    Matar MJ; Tarrand J; Raad I; Rolston KV
    Am J Infect Control; 2006 Oct; 34(8):534-6. PubMed ID: 17015161
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Timepoints of vancomycin-resistant Enterococcus colonization predict outcomes of acute myeloid leukemia patients undergoing allogeneic hematopoietic cell transplantation.
    Scheich S; Weber S; König R; Wilke AC; Lindner S; Reinheimer C; Wichelhaus TA; Hogardt M; A J Kempf V; Kessel J; Martin H; Bug G; Serve H; Steffen B
    Eur J Haematol; 2018 Jul; ():. PubMed ID: 30048011
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Breakthrough viridans streptococcal bacteremia in allogeneic hematopoietic stem cell transplant recipients receiving levofloxacin prophylaxis in a Japanese hospital.
    Kimura M; Araoka H; Yoshida A; Yamamoto H; Abe M; Okamoto Y; Yuasa M; Kaji D; Kageyama K; Nishida A; Ishiwata K; Takagi S; Yamamoto G; Asano-Mori Y; Uchida N; Hishinuma A; Izutsu K; Wake A; Taniguchi S; Yoneyama A
    BMC Infect Dis; 2016 Aug; 16():372. PubMed ID: 27495798
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Extended follow-up of an antibiotic cycling program for the management of febrile neutropenia in a hematologic malignancy and hematopoietic cell transplantation unit.
    Cumpston A; Craig M; Hamadani M; Abraham J; Hobbs GR; Sarwari AR
    Transpl Infect Dis; 2013 Apr; 15(2):142-9. PubMed ID: 23279656
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Decrease in vancomycin-resistant Enterococcus colonization associated with a reduction in carbapenem use as empiric therapy for febrile neutropenia in patients with acute leukemia.
    Ford CD; Coombs J; Stofer MG; Lopansri BK; Webb BJ; Ostronoff F; Asch J; Hoda D
    Infect Control Hosp Epidemiol; 2019 Jul; 40(7):774-779. PubMed ID: 31046849
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of Enterococcal Bacteremia in Liver Transplant Recipients.
    Kim YJ; Jun YH; Choi HJ; You YK; Kim DG; Choi JY; Yoon SK; Kim SI
    Transplant Proc; 2019 Oct; 51(8):2766-2770. PubMed ID: 31493916
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Perioperative daptomycin for prophylaxis of vancomycin-resistant Enterococcus infection in colonized liver transplant recipients.
    Mak JT; Ha S; Perloff S; Knorr JP
    Transpl Infect Dis; 2024 Feb; 26(1):e14186. PubMed ID: 37910593
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Incidence and clinical complications of vancomycin-resistant enterococcus in pediatric stem cell transplant patients.
    Tsiatis AC; Manes B; Calder C; Billheimer D; Wilkerson KS; Frangoul H
    Bone Marrow Transplant; 2004 May; 33(9):937-41. PubMed ID: 15034540
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Management of bacteremia in patients undergoing hematopoietic stem cell transplantation.
    Castagnola E; Faraci M
    Expert Rev Anti Infect Ther; 2009 Jun; 7(5):607-21. PubMed ID: 19485800
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Daptomycin perioperative prophylaxis for the prevention of vancomycin-resistant Enterococcus infection in colonized liver transplant recipients.
    Sarwar S; Koff A; Malinis M; Azar MM
    Transpl Infect Dis; 2020 Jun; 22(3):e13280. PubMed ID: 32216015
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Early vancomycin-resistant enterococcus (VRE) bacteremia after allogeneic bone marrow transplantation is associated with a rapidly deteriorating clinical course.
    Avery R; Kalaycio M; Pohlman B; Sobecks R; Kuczkowski E; Andresen S; Mossad S; Shamp J; Curtis J; Kosar J; Sands K; Serafin M; Bolwell B
    Bone Marrow Transplant; 2005 Mar; 35(5):497-9. PubMed ID: 15640812
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of Inappropriate Antibiotic Therapy in Vancomycin-Resistant Enterococcus Bacteremia.
    Aslam W; Mathew NE; Shaver C; Brito V; Jones S; Arroliga AC; Ghamande S
    Am J Ther; 2020 Sep; 28(4):e388-e396. PubMed ID: 32909964
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical characteristics and treatment outcomes of vancomycin-resistant Enterococcus faecium bacteremia.
    Ye JJ; Shie SS; Cheng CW; Yang JH; Huang PY; Wu TS; Lee MH; Huang CT
    J Microbiol Immunol Infect; 2018 Dec; 51(6):705-716. PubMed ID: 29046248
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk factors for vancomycin-resistant enterococcus bacteremia and its influence on survival after allogeneic hematopoietic cell transplantation.
    Tavadze M; Rybicki L; Mossad S; Avery R; Yurch M; Pohlman B; Duong H; Dean R; Hill B; Andresen S; Hanna R; Majhail N; Copelan E; Bolwell B; Kalaycio M; Sobecks R
    Bone Marrow Transplant; 2014 Oct; 49(10):1310-6. PubMed ID: 25111516
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.